INOVIO PHARMACEUTICALS, INC. Increase (Decrease) in Accounts Receivable
INOVIO PHARMACEUTICALS, INC. (INO) reported Increase (Decrease) in Accounts Receivable of -$220.47 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2025-11-10
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $138.28K, a 55.24% increase year-over-year.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-06-30 was -$469.93K.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-03-31 was $111.18K, a 23.77% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for the quarter ending 2024-12-31 was -$663.68K, a 354.25% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for fiscal 2024 was -$1.21M.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for fiscal 2023 was -$9.33M, a 351.82% decline from fiscal 2022.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for fiscal 2022 was $3.71M.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for fiscal 2021 was -$11.03M, a 164.83% decline from fiscal 2020.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | $138.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$331.65K derived: sum of 2 quarters · filed 2025-11-10 | -$220.47K 10-Q · filed 2025-11-10 | -$884.15K derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2025-06-30 | -$469.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$358.74K 10-Q · filed 2025-08-12 | -$1.02M derived: sum of 3 quarters · filed 2025-08-12 | -$933.35K derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2025-03-31 | $111.18K 10-Q · filed 2025-05-13 | -$552.50K derived: sum of 2 quarters · filed 2025-05-13 | -$463.43K derived: sum of 3 quarters · filed 2025-11-10 | -$1.24M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-12-31 | -$663.68K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$574.61K derived: sum of 2 quarters · filed 2025-11-10 | -$1.35M derived: sum of 3 quarters · filed 2025-11-10 | -$1.21M 10-K · filed 2025-03-18 | ||||
| 2024-09-30 | $89.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$688.34K derived: sum of 2 quarters · filed 2025-11-10 | -$542.49K 10-Q · filed 2025-11-10 | -$281.46K derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | -$777.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$631.56K 10-Q · filed 2025-08-12 | -$370.53K derived: sum of 3 quarters · filed 2025-08-12 | -$3.34M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $145.85K 10-Q · filed 2025-05-13 | $406.89K derived: sum of 2 quarters · filed 2025-05-13 | -$2.57M derived: sum of 3 quarters · filed 2025-05-13 | -$2.48M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $261.03K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$2.71M derived: sum of 2 quarters · filed 2025-03-18 | -$2.63M derived: sum of 3 quarters · filed 2025-03-18 | -$9.33M 10-K · filed 2025-03-18 | ||||
| 2023-09-30 | -$2.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$2.89M derived: sum of 2 quarters · filed 2024-11-14 | -$9.59M 10-Q · filed 2024-11-14 | -$7.94M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $81.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$6.62M 10-Q · filed 2024-08-08 | -$4.96M derived: sum of 3 quarters · filed 2024-08-08 | -$6.26M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$6.70M 10-Q · filed 2024-05-13 | -$5.05M derived: sum of 2 quarters · filed 2024-05-13 | -$6.34M derived: sum of 3 quarters · filed 2024-05-13 | -$2.46M derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $366.68K derived: sum of 2 quarters · filed 2024-03-06 | $4.25M derived: sum of 3 quarters · filed 2024-03-06 | $3.71M 10-K · filed 2024-03-06 | ||||
| 2022-09-30 | -$1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $2.59M derived: sum of 2 quarters · filed 2023-11-09 | $2.05M 10-Q · filed 2023-11-09 | $2.96M derived: sum of 4 quarters · filed 2024-03-06 | ||||
| 2022-06-30 | $3.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $3.34M 10-Q · filed 2023-08-09 | $4.25M derived: sum of 3 quarters · filed 2024-03-06 | -$2.48M derived: sum of 4 quarters · filed 2024-03-06 | ||||
| 2022-03-31 | -$541.25K 10-Q · filed 2023-05-10 | $365.71K derived: sum of 2 quarters · filed 2024-03-06 | -$6.36M derived: sum of 3 quarters · filed 2024-03-06 | -$2.77M derived: sum of 4 quarters · filed 2024-03-06 | ||||
| 2021-12-31 | $906.96K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | -$5.82M derived: sum of 2 quarters · filed 2024-03-06 | -$2.23M derived: sum of 3 quarters · filed 2024-03-06 | -$11.03M 10-K · filed 2024-03-06 | -$13.09M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | -$6.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$3.13M derived: sum of 2 quarters · filed 2022-11-08 | -$11.94M 10-Q · filed 2022-11-08 | -$13.79M 10-Q · filed 2021-11-09 | -$1.92M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-06-30 | $3.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$5.21M 10-Q · filed 2022-08-09 | -$5.43M 10-Q · filed 2021-08-09 | $4.81M derived: sum of 3 quarters · filed 2023-03-01 | $8.99M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-03-31 | -$8.80M 10-Q · filed 2022-05-10 | -$8.65M 10-Q · filed 2021-05-10 | $1.22M derived: sum of 2 quarters · filed 2023-03-01 | $5.40M derived: sum of 3 quarters · filed 2023-03-01 | $8.27M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2020-12-31 | $10.02M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $14.20M derived: sum of 2 quarters · filed 2023-03-01 | $17.07M derived: sum of 3 quarters · filed 2023-03-01 | $17.02M 10-K · filed 2023-03-01 | $17.86M 10-K · filed 2021-03-01 | |||
| 2020-09-30 | $4.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $7.05M derived: sum of 2 quarters · filed 2021-11-09 | $6.99M 10-Q · filed 2021-11-09 | $6.92M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $2.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $2.81M 10-Q · filed 2021-08-09 | $2.74M derived: sum of 3 quarters · filed 2022-03-01 | $3.38M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | -$58.43K 10-Q · filed 2021-05-10 | -$134.65K derived: sum of 2 quarters · filed 2022-03-01 | $511.41K derived: sum of 3 quarters · filed 2022-03-01 | -$2.14M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | -$76.22K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $569.84K derived: sum of 2 quarters · filed 2022-03-01 | -$2.08M derived: sum of 3 quarters · filed 2022-03-01 | -$2.62M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $646.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$2.01M derived: sum of 2 quarters · filed 2020-11-09 | -$2.54M 10-Q · filed 2020-11-09 | -$2.06M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | -$2.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$3.19M 10-Q · filed 2020-08-10 | -$2.70M derived: sum of 3 quarters · filed 2021-03-01 | -$1.58M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | -$533.10K 10-Q · filed 2020-05-11 | -$48.44K derived: sum of 2 quarters · filed 2021-03-01 | $1.07M derived: sum of 3 quarters · filed 2021-03-01 | -$2.36M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $484.65K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.60M derived: sum of 2 quarters · filed 2021-03-01 | -$1.83M derived: sum of 3 quarters · filed 2021-03-01 | -$2.69M 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $1.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$2.32M derived: sum of 2 quarters · filed 2019-11-12 | -$3.17M 10-Q · filed 2019-11-12 | -$3.41M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-06-30 | -$3.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$4.29M 10-Q · filed 2019-08-08 | -$4.52M derived: sum of 3 quarters · filed 2020-03-12 | -$5.81M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-03-31 | -$855.35K 10-Q · filed 2019-05-09 | -$1.09M derived: sum of 2 quarters · filed 2020-03-12 | -$2.37M derived: sum of 3 quarters · filed 2020-03-12 | -$4.72M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2017-12-31 | -$233.87K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$1.52M derived: sum of 2 quarters · filed 2020-03-12 | -$3.86M derived: sum of 3 quarters · filed 2020-03-12 | -$9.82M 10-K · filed 2020-03-12 | ||||
| 2017-09-30 | -$1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$3.63M derived: sum of 2 quarters · filed 2018-11-08 | -$9.58M 10-Q · filed 2018-11-08 | -$11.18M derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2017-06-30 | -$2.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$8.30M 10-Q · filed 2018-08-07 | -$9.90M derived: sum of 3 quarters · filed 2019-03-12 | -$2.81M derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2017-03-31 | -$5.96M 10-Q · filed 2018-05-09 | -$7.56M derived: sum of 2 quarters · filed 2019-03-12 | -$467.60K derived: sum of 3 quarters · filed 2019-03-12 | -$1.25M derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2016-12-31 | -$1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $5.49M derived: sum of 2 quarters · filed 2019-03-12 | $4.70M derived: sum of 3 quarters · filed 2019-03-12 | $8.52M 10-K · filed 2019-03-12 | ||||
| 2016-09-30 | $7.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $6.30M derived: sum of 2 quarters · filed 2017-11-08 | $10.12M 10-Q · filed 2017-11-08 | $6.46M derived: sum of 4 quarters · filed 2018-03-14 | ||||
| 2016-06-30 | -$786.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $3.03M 10-Q · filed 2017-08-08 | -$630.95K derived: sum of 3 quarters · filed 2018-03-14 | $4.73M derived: sum of 4 quarters · filed 2018-03-14 | ||||
| 2016-03-31 | $3.82M 10-Q · filed 2017-05-10 | $155.86K derived: sum of 2 quarters · filed 2018-03-14 | $5.51M derived: sum of 3 quarters · filed 2018-03-14 | $7.82M derived: sum of 4 quarters · filed 2018-03-14 | ||||
| 2015-12-31 | -$3.66M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $1.69M derived: sum of 2 quarters · filed 2018-03-14 | $4.00M derived: sum of 3 quarters · filed 2018-03-14 | $4.50M 10-K · filed 2018-03-14 | $4.53M 10-K · filed 2016-03-14 | |||
| 2015-09-30 | $5.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $7.67M derived: sum of 2 quarters · filed 2016-11-09 | $8.16M 10-Q · filed 2016-11-09 | $9.34M derived: sum of 4 quarters · filed 2017-03-15 | ||||
| 2015-06-30 | $2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $2.80M 10-Q · filed 2016-08-08 | $3.99M derived: sum of 3 quarters · filed 2017-03-15 | $2.73M derived: sum of 4 quarters · filed 2017-03-15 | ||||
| 2015-03-31 | $495.38K 10-Q · filed 2016-05-09 | $1.68M derived: sum of 2 quarters · filed 2017-03-15 | $421.11K derived: sum of 3 quarters · filed 2017-03-15 | $598.19K derived: sum of 4 quarters · filed 2017-03-15 | ||||
| 2014-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$74.27K derived: sum of 2 quarters · filed 2017-03-15 | $102.82K derived: sum of 3 quarters · filed 2017-03-15 | -$499.18K 10-K · filed 2017-03-15 | ||||
| 2014-09-30 | -$1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$1.08M derived: sum of 2 quarters · filed 2015-11-09 | -$1.68M 10-Q · filed 2015-11-09 | -$8.99M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2014-06-30 | $177.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$424.91K 10-Q · filed 2015-08-10 | -$7.73M derived: sum of 3 quarters · filed 2016-03-14 | $2.30M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2014-03-31 | -$601.99K 10-Q · filed 2015-05-11 | -$7.91M derived: sum of 2 quarters · filed 2016-03-14 | $2.12M derived: sum of 3 quarters · filed 2016-03-14 | $1.63M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2013-12-31 | -$7.31M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $2.72M derived: sum of 2 quarters · filed 2016-03-14 | $2.24M derived: sum of 3 quarters · filed 2016-03-14 | $2.43M 10-K · filed 2016-03-14 | $2.47M 10-K · filed 2014-03-17 | |||
| 2013-09-30 | $10.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $9.55M derived: sum of 2 quarters · filed 2014-11-10 | $9.74M 10-Q · filed 2014-11-10 | $10.09M derived: sum of 4 quarters · filed 2015-03-16 | ||||
| 2013-06-30 | -$488.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$290.09K 10-Q · filed 2014-08-11 | $58.90K derived: sum of 3 quarters · filed 2015-03-16 | $108.24K derived: sum of 4 quarters · filed 2015-03-16 | ||||
| 2013-03-31 | $198.72K 10-Q · filed 2014-05-12 | $547.71K derived: sum of 2 quarters · filed 2015-03-16 | $597.05K derived: sum of 3 quarters · filed 2015-03-16 | $152.43K derived: sum of 4 quarters · filed 2015-03-16 | ||||
| 2012-12-31 | $348.99K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $398.32K derived: sum of 2 quarters · filed 2015-03-16 | -$46.30K derived: sum of 3 quarters · filed 2015-03-16 | $362.52K 10-K · filed 2015-03-16 | ||||
| 2012-09-30 | $49.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$395.28K derived: sum of 2 quarters · filed 2013-11-12 | $13.54K 10-Q · filed 2013-11-12 | $54.50K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-06-30 | -$444.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$35.80K 10-Q · filed 2013-08-09 | $5.16K derived: sum of 3 quarters · filed 2014-03-17 | $84.29K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-03-31 | $408.82K 10-Q · filed 2013-05-10 | $449.78K derived: sum of 2 quarters · filed 2014-03-17 | $528.91K derived: sum of 3 quarters · filed 2014-03-17 | $732.35K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2011-12-31 | $40.96K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $120.09K derived: sum of 2 quarters · filed 2014-03-17 | $323.53K derived: sum of 3 quarters · filed 2014-03-17 | $435.02K 10-K · filed 2014-03-17 | ||||
| 2011-09-30 | $79.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $282.57K derived: sum of 2 quarters · filed 2012-11-07 | $394.06K 10-Q · filed 2012-11-07 | $248.29K derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-06-30 | $203.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $314.93K 10-Q · filed 2012-08-09 | $169.16K derived: sum of 3 quarters · filed 2013-03-18 | $188.12K derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-03-31 | $111.50K 10-Q · filed 2012-05-09 | -$34.27K derived: sum of 2 quarters · filed 2013-03-18 | -$15.32K derived: sum of 3 quarters · filed 2013-03-18 | |||||
| 2010-12-31 | -$145.77K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$126.81K derived: sum of 2 quarters · filed 2013-03-18 | -$226.32K 10-K · filed 2013-03-18 | |||||
| 2010-09-30 | $18.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | -$80.55K 10-Q · filed 2011-11-07 | ||||||
| 2010-06-30 | -$99.51K 10-Q · filed 2011-08-05 | |||||||
| 2009-12-31 | -$288.15K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |